Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BISU Now OTCQB Current Reporting

SAN ANTONIO, TEXAS / ACCESSWIRE / July 21, 2014 / Bio-Solutions Corp. (OTCQB: BISU), a fast growing dietary supplement manufacturer, announced today with the filing of its 10Q, Bio-Solutions Corp. (the “Company”) has regained the status as fully reporting. Company Treasurer Rick Basse remarked, “We are very excited to have completed this daunting task with the assistance of our new auditors. Now as a team, BISU will forge forward in promotion and distribution of its lead product Type 2 Defense.”

ABOUT BIO-SOLUTIONS CORP.

Bio-Solutions Corp. markets new and very effective organic products. Our lead product is Type 2 Defense, a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health conscious individuals and those diagnosed with Type II diabetes. When substituted over many popular sugars and/or carbohydrate laden alternatives, Type 2 Defense provides a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong anti-oxidants and lower carbohydrates. For more information about Type 2 Defense, visit our website http://www.type2defense.com.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

When used in this statement, the words “may,” “will,” “except,”‘ anticipate,” “continue,” “estimate,” “project,” intend” and similar expressions are intended to identify forward-looking statements within the meaning of Section 27a of the securities act of 1933 and Section 21e of the Securities Exchange Act of 1934 regarding events, condition, and financial trends that may affect the Company’s future plans of operations, business strategy, operating results, and financial position. Persons reviewing this report are cautioned that and forward-looking statements are not guarantees of future performance and are subject to risk and uncertainties and those actual results may differ materially from those include within the forward-looking statements as a result of varying factors. Such factors include among other things, uncertainties, relating to our success in judging consumer preferences, financing our operations, entering into strategic partnerships, engaging management, seasonal and period to period fluctuations in sales, failure to increase market share or sales inability to service outstanding debt obligations dependents on a limited number of customers, increased production costs or delays in production of new products intense competition within the industry, inability to protect the intellectual property in the international market for our products, changes in market conditions and other matters disclosed by us in our public filings from time to time, Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Email: info@biosolutionscorp.com
Phone: 888-208-1204

Source: Bio-Solutions Corp.